Cargando…

Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis

BACKGROUND: To improve early infant HIV diagnosis (EID) programs, options include replacing laboratory-based tests with point-of-care (POC) assays or investing in strengthened systems for sample transport and result return. SETTING: We used the CEPAC-Pediatric model to examine clinical benefits and...

Descripción completa

Detalles Bibliográficos
Autores principales: McCann, Nicole C., Cohn, Jennifer, Flanagan, Clare, Sacks, Emma, Mukherjee, Sushant, Walensky, Rochelle P., Adetunji, Oluwarantimi, Maeka, Kenneth K., Panella, Christopher, Chadambuka, Addmore, Mafaune, Haurovi, Odhiambo, Collins, Freedberg, Kenneth A., Ciaranello, Andrea L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JAIDS Journal of Acquired Immune Deficiency Syndromes 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302325/
https://www.ncbi.nlm.nih.gov/pubmed/32520910
http://dx.doi.org/10.1097/QAI.0000000000002384
_version_ 1783547822012891136
author McCann, Nicole C.
Cohn, Jennifer
Flanagan, Clare
Sacks, Emma
Mukherjee, Sushant
Walensky, Rochelle P.
Adetunji, Oluwarantimi
Maeka, Kenneth K.
Panella, Christopher
Chadambuka, Addmore
Mafaune, Haurovi
Odhiambo, Collins
Freedberg, Kenneth A.
Ciaranello, Andrea L.
author_facet McCann, Nicole C.
Cohn, Jennifer
Flanagan, Clare
Sacks, Emma
Mukherjee, Sushant
Walensky, Rochelle P.
Adetunji, Oluwarantimi
Maeka, Kenneth K.
Panella, Christopher
Chadambuka, Addmore
Mafaune, Haurovi
Odhiambo, Collins
Freedberg, Kenneth A.
Ciaranello, Andrea L.
author_sort McCann, Nicole C.
collection PubMed
description BACKGROUND: To improve early infant HIV diagnosis (EID) programs, options include replacing laboratory-based tests with point-of-care (POC) assays or investing in strengthened systems for sample transport and result return. SETTING: We used the CEPAC-Pediatric model to examine clinical benefits and costs of 3 EID strategies in Zimbabwe for infants 6 weeks of age. METHODS: We examined (1) laboratory-based EID (LAB), (2) strengthened laboratory-based EID (S-LAB), and (3) POC EID (POC). LAB/S-LAB and POC assays differed in sensitivity (LAB/S-LAB 100%, POC 96.9%) and specificity (LAB/S-LAB 99.6%, POC 99.9%). LAB/S-LAB/POC algorithms also differed in: probability of result return (79%/91%/98%), time until result return (61/53/1 days), probability of initiating antiretroviral therapy (ART) after positive result (52%/71%/86%), and total cost/test ($18.10/$30.47/$30.71). We projected life expectancy (LE) and average lifetime per-person cost for all HIV-exposed infants. We calculated incremental cost-effectiveness ratios (ICERs) from discounted (3%/year) LE and costs in $/year-of-life saved (YLS), defining cost effective as an ICER <$580/YLS (reflecting programs providing 2 vs. 1 ART regimens). In sensitivity analyses, we varied differences between S-LAB and POC in result return probability, result return time, ART initiation probability, and cost. RESULTS: For infants who acquired HIV, LAB/S-LAB/POC led to projected one-year survival of 67.3%/69.9%/75.6% and undiscounted LE of 21.74/22.71/24.49 years. For all HIV-exposed infants, undiscounted LE was 63.35/63.38/63.43 years, at discounted lifetime costs of $200/220/240 per infant. In cost-effectiveness analysis, S-LAB was an inefficient use of resources; the ICER of POC vs. LAB was $830/YLS. CONCLUSIONS: Current EID programs will attain greater benefit from investing in POC EID rather than strengthening laboratory-based systems.
format Online
Article
Text
id pubmed-7302325
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher JAIDS Journal of Acquired Immune Deficiency Syndromes
record_format MEDLINE/PubMed
spelling pubmed-73023252020-06-29 Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis McCann, Nicole C. Cohn, Jennifer Flanagan, Clare Sacks, Emma Mukherjee, Sushant Walensky, Rochelle P. Adetunji, Oluwarantimi Maeka, Kenneth K. Panella, Christopher Chadambuka, Addmore Mafaune, Haurovi Odhiambo, Collins Freedberg, Kenneth A. Ciaranello, Andrea L. J Acquir Immune Defic Syndr Supplement Article BACKGROUND: To improve early infant HIV diagnosis (EID) programs, options include replacing laboratory-based tests with point-of-care (POC) assays or investing in strengthened systems for sample transport and result return. SETTING: We used the CEPAC-Pediatric model to examine clinical benefits and costs of 3 EID strategies in Zimbabwe for infants 6 weeks of age. METHODS: We examined (1) laboratory-based EID (LAB), (2) strengthened laboratory-based EID (S-LAB), and (3) POC EID (POC). LAB/S-LAB and POC assays differed in sensitivity (LAB/S-LAB 100%, POC 96.9%) and specificity (LAB/S-LAB 99.6%, POC 99.9%). LAB/S-LAB/POC algorithms also differed in: probability of result return (79%/91%/98%), time until result return (61/53/1 days), probability of initiating antiretroviral therapy (ART) after positive result (52%/71%/86%), and total cost/test ($18.10/$30.47/$30.71). We projected life expectancy (LE) and average lifetime per-person cost for all HIV-exposed infants. We calculated incremental cost-effectiveness ratios (ICERs) from discounted (3%/year) LE and costs in $/year-of-life saved (YLS), defining cost effective as an ICER <$580/YLS (reflecting programs providing 2 vs. 1 ART regimens). In sensitivity analyses, we varied differences between S-LAB and POC in result return probability, result return time, ART initiation probability, and cost. RESULTS: For infants who acquired HIV, LAB/S-LAB/POC led to projected one-year survival of 67.3%/69.9%/75.6% and undiscounted LE of 21.74/22.71/24.49 years. For all HIV-exposed infants, undiscounted LE was 63.35/63.38/63.43 years, at discounted lifetime costs of $200/220/240 per infant. In cost-effectiveness analysis, S-LAB was an inefficient use of resources; the ICER of POC vs. LAB was $830/YLS. CONCLUSIONS: Current EID programs will attain greater benefit from investing in POC EID rather than strengthening laboratory-based systems. JAIDS Journal of Acquired Immune Deficiency Syndromes 2020-07-01 2020-06-15 /pmc/articles/PMC7302325/ /pubmed/32520910 http://dx.doi.org/10.1097/QAI.0000000000002384 Text en Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Supplement Article
McCann, Nicole C.
Cohn, Jennifer
Flanagan, Clare
Sacks, Emma
Mukherjee, Sushant
Walensky, Rochelle P.
Adetunji, Oluwarantimi
Maeka, Kenneth K.
Panella, Christopher
Chadambuka, Addmore
Mafaune, Haurovi
Odhiambo, Collins
Freedberg, Kenneth A.
Ciaranello, Andrea L.
Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis
title Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis
title_full Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis
title_fullStr Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis
title_full_unstemmed Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis
title_short Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis
title_sort strengthening existing laboratory-based systems vs. investing in point-of-care assays for early infant diagnosis of hiv: a model-based cost-effectiveness analysis
topic Supplement Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302325/
https://www.ncbi.nlm.nih.gov/pubmed/32520910
http://dx.doi.org/10.1097/QAI.0000000000002384
work_keys_str_mv AT mccannnicolec strengtheningexistinglaboratorybasedsystemsvsinvestinginpointofcareassaysforearlyinfantdiagnosisofhivamodelbasedcosteffectivenessanalysis
AT cohnjennifer strengtheningexistinglaboratorybasedsystemsvsinvestinginpointofcareassaysforearlyinfantdiagnosisofhivamodelbasedcosteffectivenessanalysis
AT flanaganclare strengtheningexistinglaboratorybasedsystemsvsinvestinginpointofcareassaysforearlyinfantdiagnosisofhivamodelbasedcosteffectivenessanalysis
AT sacksemma strengtheningexistinglaboratorybasedsystemsvsinvestinginpointofcareassaysforearlyinfantdiagnosisofhivamodelbasedcosteffectivenessanalysis
AT mukherjeesushant strengtheningexistinglaboratorybasedsystemsvsinvestinginpointofcareassaysforearlyinfantdiagnosisofhivamodelbasedcosteffectivenessanalysis
AT walenskyrochellep strengtheningexistinglaboratorybasedsystemsvsinvestinginpointofcareassaysforearlyinfantdiagnosisofhivamodelbasedcosteffectivenessanalysis
AT adetunjioluwarantimi strengtheningexistinglaboratorybasedsystemsvsinvestinginpointofcareassaysforearlyinfantdiagnosisofhivamodelbasedcosteffectivenessanalysis
AT maekakennethk strengtheningexistinglaboratorybasedsystemsvsinvestinginpointofcareassaysforearlyinfantdiagnosisofhivamodelbasedcosteffectivenessanalysis
AT panellachristopher strengtheningexistinglaboratorybasedsystemsvsinvestinginpointofcareassaysforearlyinfantdiagnosisofhivamodelbasedcosteffectivenessanalysis
AT chadambukaaddmore strengtheningexistinglaboratorybasedsystemsvsinvestinginpointofcareassaysforearlyinfantdiagnosisofhivamodelbasedcosteffectivenessanalysis
AT mafaunehaurovi strengtheningexistinglaboratorybasedsystemsvsinvestinginpointofcareassaysforearlyinfantdiagnosisofhivamodelbasedcosteffectivenessanalysis
AT odhiambocollins strengtheningexistinglaboratorybasedsystemsvsinvestinginpointofcareassaysforearlyinfantdiagnosisofhivamodelbasedcosteffectivenessanalysis
AT freedbergkennetha strengtheningexistinglaboratorybasedsystemsvsinvestinginpointofcareassaysforearlyinfantdiagnosisofhivamodelbasedcosteffectivenessanalysis
AT ciaranelloandreal strengtheningexistinglaboratorybasedsystemsvsinvestinginpointofcareassaysforearlyinfantdiagnosisofhivamodelbasedcosteffectivenessanalysis